Head And Neck Cancer Diagnostics Market To Grow By USD 6.3 Billion (2024-2028) Due To Rising Cancer Cases, AI Transforming The Market - Technavio Report

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Market Driver

Immunotherapy, a form of cancer treatment also known as biological therapy, is strengthening the body's natural defenses against head and neck cancer. Approved immunotherapies for head and neck cancer treatment include immune checkpoint inhibitors. These drugs, such as pembrolizumab (Keytruda) and nivolumab (Opdivo), trigger the immune system to destroy cancer cells. The FDA has approved these medications for persons with recurrent or metastatic head and neck squamous cell carcinoma. Keytruda, an immunotherapy used in head and neck cancer treatment, can be used as a standalone therapy or in combination with chemotherapy. It is indicated for patients whose tumors cannot be surgically removed and test positive for PD-L1. The growing acceptance and success of immunotherapy in cancer treatment are driving the demand for accurate and efficient diagnostics to identify eligible patients. Therefore, advancements in head and neck cancer diagnostics are expected to remain significant during the forecast period.

The Head and Neck Cancer Diagnostics Market is experiencing significant growth due to the rising incidence of throat cancer, thyroid nodule assessments, and the need for early detection. Pathologists play a crucial role in diagnosing these cancers through physical exams and biopsies. Diagnostic imaging technologies like MRI, CT, PET/CT, and chest imaging are essential tools for identifying tumors. Genomic testing, tumor sequencing, molecular profiling, and genetic mutation analysis are novel technologies aiding in personalized treatment plans. Clinical trials for targeted therapies and immunotherapies are underway, offering new treatment modes. Economic strategies, telemedicine, and cancer centers are also transforming the diagnostics landscape. Reimbursement issues and the rising healthcare expenditure, including hospital spending, prescription drugs, dental care, and sedentary lifestyles contributing to chronic diseases, are market challenges. Companies like Viome Life Science, CancerDetect, GE Healthcare, and skilled physicians are innovating in this space using software technologies and diagnostic devices. Oropharyngeal cancer and squamous cells are key focus areas.

Explore a 360° Analysis of the Market: Unveil the Impact of AI. For complete insights- Request Sample!

Market
Challenges

• The global head and neck cancer diagnostics market is characterized by the use of various equipment such as PET scans, CT scans, MRI, and laryngoscopy equipment. Manufacturers of these healthcare devices are subject to stringent regulations to ensure product safety and proper functioning. However, instances of faulty equipment can lead to recalls, causing significant financial setbacks for manufacturers and negatively impacting market growth. For instance, in April 2022, GE Healthcare initiated a recall of its 1.5T Signa Horizon Lx Magnetic Resonance System due to a potential safety issue with venting. In July 2021, another recall was announced for the SIGNA PET/MR due to software correction. These recalls can lead to decreased demand for cancer diagnostics equipment and hinder market expansion during the forecast period.
• The Head and Neck Cancer Diagnostics Market faces several challenges in the detection and diagnosis of various types of head and neck cancers, including throat cancer and thyroid nodule assessment. Pathologists rely on physical exams, biopsies, and diagnostic imaging for identification. Novel technologies like genomic testing, tumor sequencing, and molecular profiling help identify genetic mutations. However, economic strategies, reimbursement issues, and access to skilled physicians pose challenges. Throat cancers like oropharyngeal cancer require advanced diagnostic procedures like endoscopy and imaging techniques such as MRI, CT, PET/CT, and chest imaging. Companies like Viome Life Science, CancerDetect, GE Healthcare, and Radiologists are developing innovative diagnostic devices to address these challenges. Early detection is crucial, yet factors like sedentary lifestyle, chronic diseases, and dental care hinder timely diagnosis. Economic strategies, healthcare expenditure, personal healthcare spending, hospital spending, prescription drugs, and cancer centers play significant roles in the market's growth. Telemedicine and cancer centers offer potential solutions to overcome accessibility issues. Targeted therapy and immunotherapy are treatment modes gaining popularity, while clinical trials explore new possibilities in cancer treatment. Novel technologies and software technologies continue to emerge, providing opportunities for market expansion.

For more insights on driver and challenges
-
Request a
sample report!

Segment Overview

This head and neck cancer diagnostics market report extensively covers market segmentation by